Zurueck zur Suche

Reporte zur Charge U019905

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 4 CO 3 MI 1

VAERS 1936448

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019905

schwer
Staat
CA
Alter
14,0
Geschlecht
F
Eingang
09.12.2021
Impfdatum
08.12.2021
Beginn
08.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood glucose normal Malaise Syncope

Symptomtext

after about 1 min after vaccine pt stated she did not feel well and fainted. pt seated at all times provider called to room and was notified of reaction, provider spoke w/mother and patient, once patients vitals were stable and pt appeared better provider gave ok to discharge

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
.Glucose 102. 1400: O2:100% HR: 49 1402: O2:100% BP: 74/45 HR: 58 1405: O2: 100% BP: 75/47 HR: 84 1410: O2: 100% BP: 68/39 HR: 68 1415: O2: 100% BP: 82/51 HR: 79 1429: O2: 100% BP: 98/58 HR: 64 1440:C/O HA rates 6/10.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
nka
Vorherige Impfungen
-

VAERS 2079510

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019905

mild
Staat
CA
Alter
35,0
Geschlecht
F
Eingang
01.02.2022
Impfdatum
12.01.2022
Beginn
25.01.2022
Tage bis Beginn
13,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain Fatigue Feeling abnormal Headache Injection site rash Myalgia Peripheral swelling Rash macular Skin lesion Varicella

Symptomtext

Patient reporting on 1/25/22 around 5pm she noted a rash at injection site. Later that evening she noted another spot on her back and currently has 4-5 additional spots on her back and neck. She denies fever, but reports feeling off and fatigued with headache and muscle aches for a few days. Patient also reports right armpit was painful and swollen 1-2 days before the rash started. Patient reported symptoms to office and referral placed on 1/26/22 for patient to be evaluated by dermatology. Patient was seen by dermatology department 1/27/22 and diagnosed with vaccine induced varicella. Patient advised by dermatology to keep lesions covered, maintain wearing a mask and avoid contact with susceptible individuals. Patient currently breastfeeding so topical lidocaine and Oatmeal baths for pruritus.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Mastitis of right breast Preeclampsia in postpartum period
Vorgeschichte
POTS Hypothyroidism due to Hashimoto thyroiditis
Andere Medikamente
Zoloft 25mg tablet one by mouth daily Synthroid 25mcg tablet alternating with 50mcg Multivitamin
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2358278

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019905

gering
Staat
CA
Alter
5,0
Geschlecht
F
Eingang
05.07.2022
Impfdatum
26.05.2022
Beginn
26.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
No
Aktuelle Erkrankungen
-
Vorgeschichte
No
Andere Medikamente
No
Allergien
NKA
Vorherige Impfungen
-

VAERS 2318920

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019905

gering
Staat
-
Alter
26,0
Geschlecht
F
Eingang
14.06.2022
Impfdatum
14.06.2022
Beginn
14.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

The MMR vaccine given to the patient on 06/14/22 expired on 05/29/2022. Patient was notified immediately when the event was discovered and told to call if she noticed any adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2182324

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019905

gering
Staat
CO
Alter
1,5
Geschlecht
F
Eingang
16.03.2022
Impfdatum
14.03.2022
Beginn
14.03.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event Wrong product administered

Symptomtext

Administered 5th dose of Prevnar13 instead of Infarix (Dtap) to pt. No adverse effects noted at time of vaccination. Notified provider, supervisor, and mother of patient. Mother of patient denied any adverse effects at that time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1903494

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019905

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
27.11.2021
Impfdatum
05.11.2021
Beginn
05.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; temperature excursion; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported. On 05-NOV-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U019905, expiration date 24-JUN-2023, at a dose of 0.5 milliliter for prophylaxis (vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported). No other adverse event reported. The vaccine was stored in a temperature of 20 degree Fahrenheit for 17 (unspecified time unit). There was no previous temperature excursion reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1903493

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019905

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
27.11.2021
Impfdatum
05.11.2021
Beginn
05.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No other AE; temperature excursion; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported. On 05-NOV-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U019905, expiration date 24-JUN-2023, at a dose of 0.5 milliliter for prophylaxis (vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported). The vaccine was stored in a temperature of 20 degree Fahrenheit for 17 (unspecified time unit). There was no previous temperature excursion reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1875697

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019905

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
17.11.2021
Impfdatum
-
Beginn
01.11.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Limb injury Product container issue Speech disorder

Symptomtext

there was broken glass and she was punctured by a sliver of glass in her right index and middle finger; Accidental exposure to product; circumstance or information capable of leading to medication error; now has a Bump on her right middle finger.; Caller had rambled, pressured during call; Caller had rambled, pressured during call; there was broken glass and she was punctured by a sliver of glass in her right index and middle finger/ PQC Present?: Yes; This spontaneous report was received from a female patient of unknown age, referring to herself. The patient was not pregnant. No information was provided regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies. In approximately 04-NOV-2021 (reported as on 04-NOV-2021 or 05-NOV-2021), the patient found vials of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # U019905, expiration date reported as 21-JUN-2023, but upon internal validation established as 24-JUN-2023), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot# T034380, expiration date reported as 08-OCT-2022, but upon internal validation established as 08-JAN-2022) and sterile diluent (MERCK STERILE DILUENT) (all suspects strength, dose detail were not reported, indication for vaccines was captured as prophylaxis) in a dumpster while looking through the dumpster and there was broken glass (product container issue). She was not looking for the vial and found them by accident. The patient was punctured by a sliver of glass in her right index and middle finger (accidental exposure to product and circumstance or information capable of leading to medication error). On an unknown date in November 2021, she had a bump on her right middle finger. The patient had rambled, pressured speech during call (onset date unspecified, captured as unknown dates in November 2021). No treatment was given to the patient. The patient didn't seek medical attention. The patient was suggested to take vials to closest pharmacy and request them to dispose of vials. It was reported that the products were unable to return. The outcome of the events was unknown. The causality assessment was not reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1855761

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u019905

gering
Staat
MI
Alter
12,0
Geschlecht
F
Eingang
09.11.2021
Impfdatum
03.11.2021
Beginn
03.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Patient given Varivax second dose 51 days after first dose of Varivax. According to package insert patient should have been given this dose spaced 90 days from first dose due to her being under 13 years old. If she had been 13 years old only 28 days spacing would have been required.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-